Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Myo-inositol Plus Alpha-lactalbumin in Ovulation Induction of PCOS Myo-inositol-resistant Patients

NCT03667443 is registered in ClinicalTrials.gov with Lo.Li.Pharma s.r.l as lead sponsor.

NCT NCT03667443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03667443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Myo-inositol Plus Alpha-lactalbumin in Ovulation Induction of PCOS Myo-inositol-resistant Patients
Lead sponsor
Lo.Li.Pharma s.r.l
Phase
Not applicable
Overall status
Completed
Start date
June 13, 2022
Completion date
December 19, 2022
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myo-inositol-resistance, pcos